Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly 05 Dec 2018 Our CEO, Professor Paul Workman, discusses the findings of the ICR's new drug access report, which asks how we can best harness advances in science to bring innovative drugs to patients. Find out more Show/Hide